Conference
A prospective randomized parallel-controlled pilot trial of stereotactic body radiation therapy versus radiofrequency ablation for the management of small renal masses.
Abstract
363
Background: The potential of ablative technologies as an alternative to surgery for the treatment of small renal masses (SRMs) ≤4cm is unclear. Our objective was to evaluate the feasibility and toxicity of stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA) for SRMs in a prospective randomized pilot trial. Methods: Patients scheduled for renal cell carcinoma (RCC) treatment at a single academic …
Authors
Hoogenes J; Swaminath A; Mironov O; Tajzler C; Cassim R; Millan B; Matsumoto E; Kapoor A
Volume
40
Pagination
pp. 363-363
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2022
DOI
10.1200/jco.2022.40.6_suppl.363
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X